Literature DB >> 7447427

Method of reliable determination of minimal lethal antibiotic concentrations.

R D Pearson, R T Steigbigel, H T Davis, S W Chapman.   

Abstract

The lack of a standardized, statistically reliable method for in vitro determinations of the minimal lethal or bactericidal concentrations of antibiotics has complicated analyses of isolates of Staphylococcus aureus which appear to be inhibited but not killed by the usual concentrations of cell wall-active antibiotics. We describe a method which identifies some of the covariants involved in determinations of minimal lethal concentrations. Lethality was defined as a 99.9% reduction in the initial inoculum of bacteria after 24 h of incubation. We limited the sample volume to 0.01 ml to minimize the inhibitory effect of antibiotic and corresponding rejection values, which detected lethality with a high degree of sensitivity and specificity. When the number of colonies on subculture was equal to or less than the rejection value, the antibiotic was considered lethal for the test organism. Rejection values encompassed initial inocula from 10(5) to 10(7) colony-forming units per ml for single and duplicate samples and allowed for 1 or 5% variability in pipette volumes and errors in initial inoculum determinations. This method was used to determine the minimal lethal concentrations of semi-synthetic penicillins for S. aureau isolates, one of which was tolerant to the killing action of penicillin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7447427      PMCID: PMC284079          DOI: 10.1128/AAC.18.5.699

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  In-vitro methods for determining minimal lethal concentrations of antimicrobial agents.

Authors:  A L Barry; R A Lasner
Journal:  Am J Clin Pathol       Date:  1979-01       Impact factor: 2.493

2.  Antibiotic-tolerant Staphylococcus aureus.

Authors:  C Watanakunakorn
Journal:  J Antimicrob Chemother       Date:  1978-11       Impact factor: 5.790

3.  Variation in the susceptibility of strains of Staphylococcus aureus to oxacillin, cephalothin, and gentamicin.

Authors:  C G Mayhall; G Medoff; J J Marr
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

4.  Incidence and characteristics of antibiotic-tolerant strains of Staphylococcus aureus.

Authors:  J J Bradely; C G Mayhall; H P Dalton
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

5.  Tolerance in Staphylococcus aureus.

Authors:  H E Bradley; P L Weldy; D S Hodes
Journal:  Lancet       Date:  1979-01-20       Impact factor: 79.321

6.  Susceptibility of clinical isolates of Staphylococcus aureus to killing by oxacillin.

Authors:  G K Best; A V Koval; N H Best
Journal:  Can J Microbiol       Date:  1975-11       Impact factor: 2.419

7.  Medium-dependent variation in bactericidal activity of antibiotics against susceptible Staphylococcus aureus.

Authors:  L R Peterson; D N Gerding; W H Hall; E A Schierl
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

8.  A new type of penicillin resistance of Staphylococcus aureus.

Authors:  L D Sabath; N Wheeler; M Laverdiere; D Blazevic; B J Wilkinson
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

  8 in total
  257 in total

1.  In vitro activities of moxifloxacin and other fluoroquinolones against Mycoplasma pneumoniae.

Authors:  K Hamamoto; T Shimizu; N Fujimoto; Y Zhang; S Arai
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.

Authors:  Juliette Pavie; Agnès Lefort; Marie-Cécile Ploy; Laurent Massias; Françoise Chau; Louis Garry; François Denis; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

3.  Post-antibiotic effect of the new streptogramin RP 59500.

Authors:  N X Chin; H C Neu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

4.  Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.

Authors:  P Van der Auwera
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

5.  In vitro activity of the new fluoroquinolone CP-99,219.

Authors:  H C Neu; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

6.  Role of beta-lactamase and different testing conditions in oxacillin-borderline-susceptible staphylococci.

Authors:  J G Sierra-Madero; C Knapp; C Karaffa; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

7.  In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

8.  Bactericidal activity of oxacillin against beta-lactamase-hyperproducing Staphylococcus aureus.

Authors:  G L Woods; P Yam
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

9.  In vitro activity of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with activities of other aminoglycosides.

Authors:  J W Gu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

10.  Hyperoxia and the antimicrobial susceptibility of Escherichia coli and Pseudomonas aeruginosa.

Authors:  K H Muhvich; M K Park; R A Myers; L Marzella
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.